Visara appoints ophthalmology leaders to advance VIS-101 drug program

Go back to Visara appoints ophthalmology leaders to advance VIS-101 drug program
(NASDAQ: AURA) Delayed: 5.60 -0.1 (1.75%)
Previous Close $5.70    52 Week High
Open $5.57    52 Week Low
Day High $5.76    P/E N/A 
Day Low $5.44    EPS
Volume 188,952       

(NASDAQ: FDMT) Delayed: 8.48 -0.16 (1.85%)
Previous Close $8.64    52 Week High
Open $8.40    52 Week Low
Day High $8.68    P/E N/A 
Day Low $8.19    EPS
Volume 516,915       

(NASDAQ: NBP) Delayed: 3.50 -0.14 (3.85%)
Previous Close $3.64    52 Week High $6.95 
Open $3.56    52 Week Low $6.95 
Day High $3.71    P/E 1.64 
Day Low $3.41    EPS $2.14 
Volume 1,578,534